Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review

References

• International Diabetes Federation diabetes atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
   Google Scholar
• National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2011. Atlanta (GA): U.S. Centers for Disease Control; 2011.
   Google Scholar
• Sarlati F, Pakmehr E, Khoshru K, et al. Gingival crevicular blood for assessment of blood glucose levels. J Periodontol Implant Dentistry. 2011;2:17–24.
   Google Scholar
• Fahimipour F, Houshmand B, Alemi P, et al. The effect of He–Ne and Ga–Al–As lasers on the healing of oral mucosa in diabetic mice. J Photochem Photobiol B. 2016;159:149–154.
   PubMed Web of Science ®Google Scholar
• Nelson DL, Cox MM. Lehninger principles of biochemistry. New York: W. H. Freeman and Company; 2005.
   Google Scholar
• Yazdanpanah S, Rabiee M, Tahriri M, et al. Glycated hemoglobin-detection methods based on electrochemical biosensors. TrAC Trends Anal Chem. 2015;72:53–67.
   Web of Science ®Google Scholar
• Sejling AS, Schouwenberg B, Faerch L, et al. Association between hypoglycaemia and impaired hypoglycaemia awareness and mortality in people with Type 1 diabetes mellitus. Diabetic Med. 2016;33:77–83.
   PubMed Web of Science ®Google Scholar
• Booth G, Shah B, Austin P, et al. Early specialist care for diabetes: who benefits most? A propensity score‐matched cohort study. Diabetic Med. 2016;33:111–118.
   PubMed Web of Science ®Google Scholar
• Son JW. Hypoglycemic morbidity and mortality in diabetes. J Korean Diabetes. 2016;17:17–23.
   Google Scholar
• Beshyah SA. 2016. IDF-DAR practical guidelines for management of diabetes during ramadan. Ibnosina J Med Biomed Sci. 8:58–60.
   Google Scholar
• Franklin V. Influences on technology use and efficacy in type 1 diabetes. J Diabetes Sci Technol. 2016;10:647–655.
   PubMedGoogle Scholar
• Kovacs Burns K, Holt R, Nicolucci A, et al. Correlates of psychological outcomes among family members of people with diabetes in the second diabetes attitudes, wishes and needs (DAWN2™) study. Diabetic Med. 2016.
   Web of Science ®Google Scholar
• Anguizola J, Matsuda R, Barnaby OS, et al. Review: glycation of human serum albumin. Clin Chim Acta. 2013;425:64–76.
   PubMed Web of Science ®Google Scholar
• Olijhoeka J, Graafb Y, Bangaa J, et al. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25:342–348.
   PubMed Web of Science ®Google Scholar
• Hartog J, Voors A, Bakker S, et al. Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail. 2007;9:1146–1155.
   PubMed Web of Science ®Google Scholar
• Perneger T, Brancati FL, Whelton P, et al. End-stage renal disease attributable to diabetes mellitus. Ann Intern Med. 1994;121:912–918.
   PubMed Web of Science ®Google Scholar
• Turk Z, Misur I, Turk N. Temporal association between lens protein glycation and cataract development in diabetic rats. Acta Diabetol. 1997;34:49–54.
   PubMed Web of Science ®Google Scholar
• Bild D, Selby J, Sinnock P, et al. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care. 1989;12:24–31.
   PubMed Web of Science ®Google Scholar
• Association AD 2. Classification and diagnosis of diabetes. Diabetes Care. 2016;39(Supplement 1):S13–S22.
   Google Scholar
• Thornalley P, Langborg A, Minhas H. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999;344:109–116.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346–1353.
   PubMed Web of Science ®Google Scholar
• Zheng R. The development of an aptamer-based surface plasmon resonance (SPR) sensor for the real-time detection of glycated protein: Toledo; 2012.
   Google Scholar
• Furusyo N, Furusyo N, Koga T, et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 2011;54:3028–3036.
   PubMed Web of Science ®Google Scholar
• Mittman N, Desiraju B, Fazil I, et al. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Kidney Int Suppl. 2010;117:S41–S45.
   Web of Science ®Google Scholar
• Schleicher ED, Olgemöller B, Wiedenmann E, et al. Specific glycation of albumin depends on its half-life. Clin Chem. 1993;39:625–628.
   PubMed Web of Science ®Google Scholar
• Zheng C-M, Ma W-Y, Wu C-C, et al. Glycated albumin in diabetic patients with chronic kidney disease. Clin Chim Acta. 2012;413:1555–1561.
   PubMed Web of Science ®Google Scholar
• Zheng C-M, Ma W-Y, Wu C-C, et al. Glycated albumin in diabetic patients with chronic kidney disease. Clinica Chimica Acta. 2012;413:1555–1561.
   PubMed Web of Science ®Google Scholar
• Mukharjee K. Medical laboratory technology. A procedure manual for routine diagnostic tests. Vol. I–III. New Delhi: Tata McGraw-Hill Publishing Company Limited; 1997.
   Google Scholar
• Peters T. All about albumin: biochemistry, genetics, and medical applications. San Diego: Elsevier. 1996.
   Google Scholar
• Ueda Y, Matsumoto H. Recent topics in chemical and clinical research on glycated albumin. J Diabetes Sci Technol. 2015;9:177–182.
   PubMedGoogle Scholar
• Curry S, Mandelkow H, Brick P, et al. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998;5:827–835.
   PubMed Web of Science ®Google Scholar
• Leslie RDG, Cohen RM. Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications. J Diabetes Sci Technol. 2009;3:635–643.
   PubMedGoogle Scholar
• Peacock T, Shihabi Z, Bleyer A. Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int. 2008;73:1062–1068.
   PubMed Web of Science ®Google Scholar
• Roohk H, Zaidi A. A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol. 2008;2:1114–1121.
   PubMedGoogle Scholar
• Guerin-Dubourg A, Catan A, Bourdon E, et al. Structural modifications of human albumin in diabetes. Diabetes Metab. 2012;38:171–178.
   PubMed Web of Science ®Google Scholar
• Amer Diabet. Standards of Medical Care in Diabetes-2011 American Diabetes Association. Diabetes Care. 2011;34:S11–S61.
   PubMed Web of Science ®Google Scholar
• Bry L, Chen P, Sacks D. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153–163.
   PubMed Web of Science ®Google Scholar
• Cohen M. Measurement of circulating glycated proteins to monitor intermediateterm changes in glycaemic control. Eur J Clin Chem Clin Biochem. 1992;30:851–859.
   PubMedGoogle Scholar
• Szkudlarek A, Sułkowska A, Maciazek-Jurczyk M, et al. Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis. Acta Part A: Mol Biomol Spectroscopy. 2015;152:645–653.
   PubMed Web of Science ®Google Scholar
• Cohen M, Hud E. Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA. J Immunol Methods. 1989;122:279–283.
   PubMed Web of Science ®Google Scholar
• Hage DS, Anguizola JA, Cong Bi RL, et al. Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments. J Pharm Biomed Anal. 2012;69:93–105.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Sakamoto Y, Kawasaki Y, et al. Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA). Clin Chem. 1998;44:256–263.
   PubMed Web of Science ®Google Scholar
• Guthrow CE, Morris MA, Day JF, et al. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA. 1979;76:4258–4261.
   PubMed Web of Science ®Google Scholar
• Paroni R, Ceriotti F, Galanello R, et al. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007;40:1398–1405.
   PubMed Web of Science ®Google Scholar
• Kohzuma T, Koga M. Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus. Mol Diagn Ther. 2010;14:49–51.
   PubMed Web of Science ®Google Scholar
• Kohzuma T, Yamamoto A, Uematsu Y, et al. Basic performance of an enzymatic method for glycated albumin and reference range determination. J Diabetes Sci Technol. 2011;5:1455–1462.
   PubMedGoogle Scholar
• Ohe Y, Matsuura M, Nakajima Y, et al. Radioimmunoassay of glycosylated albumin with monoclonal antibody to glucitol-lysine. Clin Chim Acta. 1987;169:229–238.
   PubMed Web of Science ®Google Scholar
• Reed P, Bhatnagar D, Dhar H, et al. Precise measurement of glycated serum albumin by column affinity chromatography and immunoturbidimetry. Clin Chim Acta. 1986;161:191–199.
   PubMed Web of Science ®Google Scholar
• Yatscoff R, Tevaarwerk G, MacDonald J. Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography. Clin Chem. 1984;30:446–449.
   PubMed Web of Science ®Google Scholar
• Guthrow CE, Morris MA, Day JF, et al. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci. 1979;76:4258–4261.
   PubMed Web of Science ®Google Scholar
• Day JF, Thorpe SR, Baynes JW. Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. J Biol Chem. 1979;254:595–597.
   PubMed Web of Science ®Google Scholar
• Yasukawa K, Abe F, Shida N, et al. High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin. J Chromatography A. 1992;597:271–275.
   PubMed Web of Science ®Google Scholar
• Tominaga M, Makino H, Yoshino G, et al. Report of the Committee on Standardization of Laboratory Testing Related to Diabetes Mellitus of the Japan Diabetes Society: determination of Reference Intervals Hemoglobin Aic (IFCC) and Glycoalbumin in Japanese Population. J Japan Diabetes Soc. 2006;49:825.
   Google Scholar
• Muramoto Y, Matsushita M, Irino T. Reduction of reaction differences between human mercaptalbumin and human nonmercaptalbumin measured by the bromcresol purple method. Clin Chim Acta. 1999;289:69–78.
   PubMed Web of Science ®Google Scholar
• Heller GT, Zwang TJ, Sazinsky MH, et al. Resolving the effects of albumin glycation using the quartz crystal microbalance. EDP Sci. 2013;4.
   Google Scholar
• Seneviratne C, Narayanan R, Liu W, et al. The in vitro inhibition effect of 2 nm gold nanoparticles on non-enzymatic glycation of human serum albumin. Biochem Biophys Res Commun. 2012;422:447–454.
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Bhattacharya R, Bone N, et al. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL) enhancing apoptosis. Nanobiotechnol J. 2007;5:76–97.
   Google Scholar
• Krpetic Z, Porta F, Scari G. Selective entrance of gold nanoparticles into cancer cells. Gold Bull. 2006;39:65–68.
   Web of Science ®Google Scholar
• Cao JJ, Hudson M, Jankowski M, et al. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol. 2005;96:183–186.
   PubMed Web of Science ®Google Scholar
• Gæde P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–393.
   PubMed Web of Science ®Google Scholar
• Koenig R, Peterson C, Jones R, et al. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med. 1976;295:417–420.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Nagake Y, Takahashi M, et al. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Nippon Jinzo Gakkai Shi. 1996;38:305–308.
   PubMedGoogle Scholar
• Joy M, Cefalu W, Hogan S, et al. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis. 2002;39:297–307.
   PubMed Web of Science ®Google Scholar
• Nakao T, Matsumoto H, Okada T, et al. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern Med. 1998;38:826–830.
   Web of Science ®Google Scholar
• Kosecki S, Rodgers P, Adams M. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy. Ann Pharmacother. 2005;39:1557–1560.
   PubMed Web of Science ®Google Scholar
• Koga M. Glycated albumin; clinical usefulness. Clin Chim Acta. 2014;433:96–104.
   PubMed Web of Science ®Google Scholar
• Kouzuma T. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta. 2004;346:135–143.
   PubMed Web of Science ®Google Scholar
• Tominaga M, Makino H, Yoshino G, et al. Japanese standard reference material JDS Lot 2 for haemoglobin A1c. II: Present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays. Ann Clin Biochem. 2005;42:47–50.
   PubMed Web of Science ®Google Scholar
• Tarim Ö, Küçükerdogan A, Günay Ü, et al. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int. 1999;41:357–362.
   PubMed Web of Science ®Google Scholar
• Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112:126–128.
   PubMed Web of Science ®Google Scholar
• Inoue K, Tsujimoto T, Yamamoto-Honda R, et al. A newer conversion equation for the correlation between HbA1c and glycated albumin. Japan Endocr Soc. 2014;61:553–560.
   Google Scholar
• Moriya T, Matsubara M, Koga M. Hemoglobin A1C but not glycated albumin overestimates glycemic control due to iron deficiency in pregnant women with diabetes. J Diabetes Metab. 2014;5:1–4.
   Google Scholar
• Suzuki S, Koga M, Niizeki N, et al. Evaluation of glycated hemoglobin and fetal hemoglobin-adjusted HbA1c measurements in infants. Pediatr Diabetes. 2013;14:267–272.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Koga M, Amamiya S, et al. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus. Diabetologia. 2011;54:2247–2253.
   PubMed Web of Science ®Google Scholar
• Koga M, Murai J, Saito H, et al. Evaluation of the glycated albumin/HbA1c ratio by stage of diabetic nephropathy. Diabetol Int. 2011;2:141–145.
   Google Scholar
• Koga M, Hashimoto K, Murai J, et al. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin Chim Acta. 2011;412:253–257.
   PubMed Web of Science ®Google Scholar
• Koga M, Murai J, Saito H, et al. Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women. Acta Diabetol. 2010;47:65–69.
   PubMed Web of Science ®Google Scholar
• Yasumoto M, Tsuda A, Ishimura E, et al. Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects – study of insulin and para-aminohippuric acid clearance in humans. Physiol Rep. 2015;3.
   PubMedGoogle Scholar
• Koga M, Murai J, Saito H, et al. Usefulness of glycated albumin as a glycemic control marker after iron treatment for diabetic patients with iron deficiency anemia. J Jpn Diab Soc. 2009;52:341–345.
   Google Scholar
• Hashimoto K, Noguchi S, Morimoto Y. A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care. 2008;31:1945–1948.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Osugi T, Noguchi S. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care. 2010;33:509–511.
   PubMed Web of Science ®Google Scholar
• Shimizu I, Hiramatsu Y, Omori Y, et al. Glycated albumin reflects maternal and perinatal outcome in a multicenter study in Japan. Diabetes Pregnancy. 2010;10:27–31.
   Google Scholar
• Miyazaki A, Kohzuma T, Kasayama S, et al. Classification of variant forms of hemoglobin according to the ratio of HbA1c to glycated albumin. Ann Clin Biochem. 2012;49:441–444.
   PubMed Web of Science ®Google Scholar
• Ijima H, Jinnouchi H, Hamaguchi K. Cases with Hb Toranomon show abnormal HbA1c levels measured by upgraded high-performance liquid chromatography models. Diabetol Int. 2001;2:202–207.
   Google Scholar
• Nishihara E, Koga M, Kadowaki S. Method-dependent HbA1c values in a family with hemoglobin Himeji. Clin Chim Acta. 2011;412:1689–1692.
   PubMed Web of Science ®Google Scholar
• Panzer S, Kronik G, Lechner K, et al. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood. 1982;59:1348–1350.
   PubMed Web of Science ®Google Scholar
• Panzer S, Graninger W, Kronik G, et al. Glycosylated hemoglobin as a long-term parameter in appraising the severity of hemolytic disease. Klin Wochenschr. 1983;61:839–843.
   PubMedGoogle Scholar
• Gram-Hansen P, Mourits-Andersen H, Eriksen J, et al. Glycosylated haemoglobin (HbA1c) as an index of the age of the erythrocyte population in nondiabetic patients. Eur J Haematol. 1990;44:201–203.
   PubMed Web of Science ®Google Scholar
• Nomura Y, Nanjo N, Miyano M. Hemoglobin A1 in cirrhosis of the liver. Diabetes Res. 1989;11:177–180.
   PubMedGoogle Scholar
• Koga M, Kasayama S, Kanehara H, et al. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract. 2008;81:258–262.
   PubMed Web of Science ®Google Scholar
• Inaba M, Okuno S, Kumeda Y. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18:896–903.
   PubMed Web of Science ®Google Scholar
• Lee S-Y, Chen Y-C, Tsai I-C, et al. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients. Plos One. 2013;8.
   Web of Science ®Google Scholar
• Goldstein D, Little R, Lorenz R, et al. Tests of glycemia in diabetes. Diabetes Care. 1995;18:896–909.
   PubMed Web of Science ®Google Scholar
• Ly J, Marticorena R, Donnelly S. Red blood cell survival in chronic renal failure. Am J Kidney Dis. 2004;44:715–719.
   PubMed Web of Science ®Google Scholar
• Freedman BI, Shenoy RN, Planer JA, et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int. 2010;30:72–79.
   PubMed Web of Science ®Google Scholar
• Coronel F, Macia M, Cidoncha A, et al. Fructosamine levels in CAPD: its value as glycemic index. Adv Perit Dial. 1991;7:253–256.
   PubMedGoogle Scholar
• Nathan DM, McGee P, Steffes MW, et al. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014;63:282–290.
   PubMed Web of Science ®Google Scholar
• DCCT Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes. 1995;44:968–983.
   PubMed Web of Science ®Google Scholar
• Felner E, McGrath M. Inaccurate hemoglobin A(1C) levels in patients with type 1 diabetes and hereditary persistence of hemoglobin F. J Pediatr. 2008;153:137–139.
   PubMed Web of Science ®Google Scholar
• Rohlfing CL, Connolly SM, England JD, et al. The effect of elevated fetal haemoglobin on haemoglobin A1c results: five common haemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol. 2008;129:811–814.
   PubMed Web of Science ®Google Scholar
• Lanzkron S, Strouse JJ, Wilson R, et al. Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Int Med. 2008;148:939–955.
   PubMed Web of Science ®Google Scholar
• Ngo DA, Aygun B, Akinsheye I, et al. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin. Br J Haematol. 2012;156:259–264.
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Murase-Mishiba Y, Yamamoto N, et al. Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes. Intern Med. 2012;51:1315–1321.
   PubMed Web of Science ®Google Scholar
• Shen Y, Pu LJ, Lu L, et al. Glycated albumin is superior to hemoglobin A1c for evaluating the presence and severity of coronary artery disease in type 2 diabetic patients. Cardiology. 2012;123:84–90.
   PubMed Web of Science ®Google Scholar
• Y, Shen LL, Ding F, Sun Z, et al. Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion. Cardiovasc Diabetol. 2013;12:165.
   PubMed Web of Science ®Google Scholar
• Ikeda N, Hara H, Hiroi Y. 1,5-Anhydro-d-glucitol predicts coronary artery disease prevalence and complexity. J Cardiol. 2014;64:297–301.
   PubMed Web of Science ®Google Scholar
• Hirsch IB, Amiel SA, Blumer IR, et al. Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers. Diabetes Technol Ther. 2012;14:973–983.
   PubMed Web of Science ®Google Scholar
• Mabuchi H, Koizumi J, Shimizu M, et al. Development of coronary heart disease in familial hypercholesterolemia. Circulation. 1989;79:225–232.
   PubMed Web of Science ®Google Scholar
• Ma X, Shen Y, Hu X, et al. Associations of glycated hemoglobin A1c and glycated albumin with subclinical atherosclerosis in middle-aged and elderly Chinese population with impaired glucose regulation. Clin Exp Pharmacol Physiol. 2015;42:582–587.
   PubMed Web of Science ®Google Scholar
• Saisho Y, Tanaka K, Abe T, et al. Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes. Endocrine J. 2014;2:149–157.
   Google Scholar
• Lee JE, Lee JW, Fujii T, et al. The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing B-cell function in childhood diabetes. BioMed Res Int. 2014:370790.
   PubMed Web of Science ®Google Scholar
• Yasumoto M, Tsuda A, Ishimura E, et al. Significant association between glycemic status and increased estimated postglomerular resistance in nondiabetic subjects–study of insulin and para‐aminohippuric acid clearance in humans. Physiol Rep. 2015;3:e12321.
   PubMedGoogle Scholar
• Kitamura T, Otsuki M, Tamada D, et al. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing’s syndrome. Clin Chim Acta. 2013;424:164–167.
   PubMed Web of Science ®Google Scholar
• Koga M, Saito H, Mukai M, et al. Serum glycated albumin levels are influenced by smoking status, independent of plasma glucose levels. Acta Diabetol. 2009;46:141–144.
   PubMed Web of Science ®Google Scholar
• Bando Y, Kanehara H, Toya D, et al. Association of serum glycated albumin to glycated haemoglobin A1c ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem. 2009;46:368–372.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Koga M, Niizeki N, et al. Glycated albumin is lower in infants than in adults and correlated with both age and serum albumin. Pediatr Diabetes. 2013;14:25–30.
   PubMed Web of Science ®Google Scholar
• Suzuki S, Koga M, Takahashi H, et al. Glycated albumin in patients with neonatal diabetes mellitus is apparently low in relation to glycemia compared with that in patients with type 1 diabetes mellitus. Horm Res Paediatr. 2012;27:273–276.
   Web of Science ®Google Scholar
• Koga M, Murai J, Saito H, et al. Effect of thyroid hormone on serum glycated albumin levels: study on non-diabetic subjects. Diabetes Res Clin Pract. 2009;84:163–167.
   PubMed Web of Science ®Google Scholar
• Okada T, Nakao T, Matsumoto H, et al. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Intern Med. 2011;50:23–29.
   PubMed Web of Science ®Google Scholar
• Nishimura R, Kanda A, Sano H. Glycated albumin is low in obese, non-diabetic children. Diabetes Res Clin Pract. 2006;71:334–338.
   PubMed Web of Science ®Google Scholar
• Koga M, Otsuki M, Matsumoto S, et al. Negative association of obesity and its related chronic inflammationwith serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta. 2007;378:48–52.
   PubMed Web of Science ®Google Scholar
• Don B, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432–437.
   PubMed Web of Science ®Google Scholar